UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
(Amendment No.)
Filed by the Registrant þ
Filed by a Party other than
the ¨
Registrant
Check the appropriate box:
¨ Preliminary
Proxy Statement
¨ Confidential,
for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
¨ Definitive
Proxy Statement
þ Definitive
Additional Materials
¨ Soliciting
Material under §240.14a-12
OPIANT PHARMACEUTICALS, INC.
(Name of Registrant as Specified in its Charter)
N/A
(Name of Person(s) Filing Proxy Statement, if Other Than the
Registrant)
Payment of Filing Fee (Check the appropriate box):
þ No
fee required.
¨ Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
◦Title
of each class of securities to which transaction
applies:
◦Aggregate
number of securities to which transaction applies:
◦Per
unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was
determined):
◦Proposed
maximum aggregate value of transaction:
◦Total
fee paid:
¨ Fee
paid previously with preliminary materials.
¨ Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date
of its filing.
1.Amount
Previously Paid:
2.Form,
Schedule or Registration Statement No.:
3.Filing
Party:
4.Date
Filed:
Additional Information Regarding Opiant Pharmaceuticals’ Annual
Meeting of Stockholders to be Held on June 14, 2022
Opiant Pharmaceuticals issued the following press release on May
20, 2022, which relates to its proxy statement dated April 18,
2022, and furnished to its stockholders in connection with the
solicitation of proxies for use at its annual meeting of
stockholders to be held on Tuesday, June 14, 2022.
This supplement is being filed with the Securities and Exchange
Commission and was made available to stockholders on May 23,
2022.
This supplement should be read in conjunction with Opiant
Pharmaceuticals’ proxy statement dated April 18, 2022.
Opiant Pharmaceuticals to Hold Virtual 2022 Annual Shareholder
Meeting on Tuesday, June 14, 2022 at 9:00am PDT
SANTA MONICA, CA., May 20, 2022
-- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT),
announced today that to protect the health and safety of its
shareholders, employees, and communities amidst a rise locally in
COVID-19, Opiant's 2022 Annual Meeting of Shareholders will be held
in a virtual-only meeting format via live audio webcast. The
meeting will be held online only and will begin at 09:00 AM PDT on
June 14, 2022, as previously scheduled. The matters to be voted on
at the 2022 Annual Meeting, remain unchanged.
The Company’s proxy statement describing the formal business to be
conducted at the meeting is available on the Investors section of
the Company’s website at:
https://ir.opiant.com/static-files/2112e0ec-9025-42f9-9204-084a734d662b
Shareholders who elect to virtually attend the meeting may do so as
follows:
Date: Tuesday, June 14, 2022
Time: 9:00 a.m. (PDT)
Live Virtual Meeting: https://zoom.us/j/95041888598 (Meeting ID:
950 4188 8598)
Find your local number via
https://zoom.us/u/apRdfUhqI
Shareholders of record at the close of business on April 18, 2021,
the record date for the 2022 Annual Meeting, are entitled to
participate in the virtual meeting and will need their assigned
16-digit control number to vote shares electronically at the
virtual meeting by submitting an email to:
Admin12@astfinancial.com
Important Information for Voting Shares
Your vote is important.
Whether or not shareholders plan to attend the virtual-only annual
meeting, Opiant urges shareholders to vote and submit their proxies
in advance of the meeting by one of the methods described in the
proxy materials.
Shareholders of record with Internet access may submit proxies
until 11:59 p.m., Eastern Time, on June 14, 2022, by following the
instructions on your proxy cards or at
www.voteproxy.com.
Shareholders who have already voted their shares do not need to
vote them again because of this change in meeting
format.
A list of shareholders entitled to vote at the 2022 Annual Meeting
will be available for review by interested shareholders. Please
contact the Company’s Investor Relations by sending an e-mail
to
batkins@opiant.com,
if you wish to inspect the list prior to the meeting.
Attending the Annual Meeting as a Guest
Those without a control number may attend the virtual meeting as
guests, but will not have the option to vote.
About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN®
Nasal Spray, is building a leading franchise of new medicines to
combat addictions and drug overdose.
For more information visit: www.opiant.com.
# # #
Important Notice of Availability of Proxy Materials for the
Stockholder Meeting of
OPIANT PHARMACEUTICALS, INC.
To Be Held On:
June 14, 2022 at 9:00 a.m.
Live Virtual Meeting: http://zoom.us/j/95041888598
Meeting ID: 95041888598
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company Number |
|
|
|
|
|
|
|
Account Number |
|
|
|
|
|
|
|
Control Number |
|
|
|
This communication presents only an overview of the more complete
proxy materials that are available to you on the Internet. We
encourage you to access and review all of the important information
contained in the proxy materials before voting.
If you want to receive a paper or e-mail copy of the proxy
materials you must request one.
There is no charge to you for requesting a copy. To facilitate
timely delivery please make the request as instructed below before
06/05/22.
Please visit http://www.astproxyportal.com/ast/21992/, where the
following materials are available for view:
*
Notice of Annual Meeting of Stockholders
*
Proxy Statement
*
Form of Electronic Proxy Card
*
Annual Report on Form 10-K
|
|
TO REQUEST
MATERIAL: |
TELEPHONE: 888-Proxy-NA (888-776-9962) 718-921-8562 (for
international callers)
E-MAIL: info@astfinancial.com
WEBSITE:
https://us.astfinancial.com/OnlineProxyVoting/ProxyVoting/RequestMaterials
|
|
TO VOTE: |
|
ONLINE:
To access your online proxy card, please visit www.voteproxy.com
and follow the on-screen instructions or scan the QR code with your
smartphone. You may enter your voting instructions at
www.voteproxy.com up until 11:59 PM Eastern Time the day before the
cut-off or meeting date.
IN PERSON:
You may vote your shares in person by attending the Annual
Meeting.
TELEPHONE:
To vote by telephone, please visit www.voteproxy.com to view the
materials and to obtain the toll free number to call.
MAIL:
You may request a card by following the instructions
above.
|
|
|
|
|
|
|
|
|
|
|
1.Election
of Directors:
|
|
|
2. Ratification of Independent Registered Public Accounting
Firm.
|
|
NOMINEES:
|
|
|
3. Advisory Approval of our Executive Compensation |
|
Dr. Roger Crystal |
|
|
|
|
|
|
|
|
Ann MacDougall |
|
|
|
|
|
|
|
|
|
|
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" THE LISTED NOMINEES,
"FOR" PROPOSALS 2 AND 3. |
|
|
|
|
|
|
|
|
|
|
|
Please note that you cannot use this notice to vote by
mail. |
|
|
|
|
|
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From May 2022 to Jun 2022
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Jun 2021 to Jun 2022
